When a child or family member is diagnosed with thalassaemia, the path forward can feel uncertain. Regular hospital visits, blood transfusions, and ongoing monitoring become part of daily life – and for many Sri Lankan families, the search for more definitive treatment eventually leads to India.
Thalassaemia treatment in India has become an increasingly important pathway for Sri Lankan patients, offering access to dedicated haematology programmes, advanced iron overload management, bone marrow transplant evaluation, and for carefully selected patients, the possibility of a cure.
This guide explains what thalassaemia is, how it is treated, and how Sri Lankan patients and families can access specialist care at Amrita Hospitals.
What Is Thalassaemia?
Thalassaemia is fundamentally a disorder of haemoglobin production. Haemoglobin is the protein inside red blood cells responsible for carrying oxygen from the lungs to every tissue in the body.
A helpful way to understand it: imagine the body as a factory whose entire purpose is to produce haemoglobin – tiny delivery vehicles that transport life-giving oxygen throughout the body. In a person with thalassaemia, a genetic error in the factory’s instruction manual means it either makes these delivery vehicles too small, the wrong shape, or simply does not make enough of them.
As a result of this disruption in haemoglobin production:
- The body produces abnormal or insufficient haemoglobin
- Red blood cells become smaller and more fragile than normal
- Red blood cells are broken down more rapidly than the body can replace them
- The body is left in a state of chronic anaemia – insufficient healthy red blood cells to deliver adequate oxygen to tissues
This oxygen deficiency is the root cause of the symptoms thalassaemia patients experience day to day.
What Are the Types of Thalassaemia?
Thalassaemia exists on a clinical spectrum, determined by the genetic mutations inherited and the number of affected genes:
Alpha Thalassaemia
Caused by mutations affecting the alpha globin genes. Ranges from a silent carrier state with no symptoms, to haemoglobin H disease causing moderate anaemia, to the most severe form – Hb Bart’s hydrops fetalis – which is incompatible with life without intervention.
Beta Thalassaemia
Caused by mutations affecting the beta globin genes. The most clinically significant form for Sri Lankan patients:
- Beta Thalassaemia Minor (Thalassaemia Trait) – the person carries one affected gene. Usually causes mild anaemia or no symptoms. Carriers can pass the condition to their children
- Beta Thalassaemia Intermedia – moderate severity. Patients may not require regular transfusions but need careful monitoring and management
- Beta Thalassaemia Major (Cooley’s Anaemia) – the most severe form. Both beta globin genes are affected. Patients require lifelong regular blood transfusions beginning in early childhood to survive. Without treatment, severe anaemia, organ damage, and life-threatening complications develop rapidly
Sri Lanka has a relatively high carrier rate for beta thalassaemia, making genetic screening and counselling particularly important for couples planning a family.
What Symptoms Does Thalassaemia Cause?
The symptoms of thalassaemia – particularly beta thalassaemia major – reflect the body’s chronic oxygen deficit and the consequences of the disease and its treatment over time:
Symptoms of Anaemia
- Constant exhaustion and fatigue – like a battery that never fully charges, even after adequate sleep
- Pale or yellowish skin – the body is struggling to maintain healthy, well-oxygenated blood
- Shortness of breath with activities that others find easy
- Rapid heart rate as the heart works harder to compensate for reduced oxygen delivery
Symptoms of Chronic Disease and Iron Overload
- Delayed growth and delayed puberty in children
- Enlarged spleen (splenomegaly) – the spleen works overtime to clear abnormal red blood cells
- Bone changes – the bone marrow expands in an attempt to produce more red blood cells, causing characteristic facial and skeletal changes
- Endocrine problems – iron accumulation from repeated transfusions damages the liver, heart, thyroid, and other hormone-producing glands over time
Living with thalassaemia – particularly the major form – means becoming skilled at managing energy, attending regular medical appointments, and in many cases receiving blood transfusions on a scheduled basis throughout life.
Is Thalassaemia Related to Neurology?
Thalassaemia is not primarily a neurological disorder – it is a genetic haematological condition affecting haemoglobin production. However, it is closely connected to neurology because of the secondary neurological complications that can develop, particularly as patients live longer with improved medical care.
Neurological Complications Associated With Thalassaemia
- Peripheral neuropathy – many patients develop mild sensory or sensorimotor nerve involvement over time. Symptoms include numbness, tingling, a pins and needles sensation, muscle cramps, and limb weakness
- Cerebrovascular disease – thalassaemia creates a state of increased clotting tendency (hypercoagulability), raising the risk of thromboembolic events including overt strokes and silent cerebral infarcts – asymptomatic brain lesions detectable only on MRI
- Cognitive effects – some patients show lower scores on measures of working memory, attention, and cognitive processing compared to healthy individuals of the same age
- Abnormal evoked potentials – electrophysiological changes affecting sensory, visual, and auditory neural pathways
- Extramedullary haematopoiesis – in some cases the body attempts to produce red blood cells outside the bone marrow in locations including the spinal canal or skull, potentially causing spinal cord or cranial nerve compression
Why Do These Neurological Complications Occur?
The neurological effects of thalassaemia arise from a combination of factors related to the disease itself and its treatment:
- Chronic hypoxia – severe anaemia reduces oxygen supply to the brain and peripheral nerves, causing gradual nerve damage and cognitive effects
- Iron overload – frequent blood transfusions lead to systemic iron accumulation. Excess iron damages brain tissue through oxidative stress, a process known as ferroptosis
- Medication effects – certain iron chelation medications including deferoxamine can cause damage to the optic nerve, auditory nerve, and sensory pathways if not carefully monitored and dosed
- Prothrombotic state – repeated red blood cell destruction and, in some patients, splenectomy raise platelet levels, increasing the risk of stroke and brain ischaemia
For Sri Lankan patients and families managing thalassaemia, this connection with neurology underlines the importance of comprehensive specialist care – not only haematological management but regular neurological monitoring as part of long-term follow-up.
How Is Thalassaemia Diagnosed?
Thalassaemia is diagnosed through a combination of blood tests and genetic analysis:
- Full blood count (FBC) – reveals anaemia, small red blood cells (microcytosis), and reduced haemoglobin levels
- Peripheral blood smear – microscopic examination of red blood cell morphology
- Haemoglobin electrophoresis or HPLC – identifies abnormal haemoglobin types and confirms the type and severity of thalassaemia
- Iron studies – to assess iron levels and distinguish thalassaemia trait from iron deficiency anaemia
- Genetic testing – DNA analysis to identify specific mutations, which guides prognosis and informs genetic counselling
- Ferritin and organ function monitoring – particularly important in patients receiving regular transfusions
Prenatal and Carrier Screening
Because thalassaemia is an inherited condition, carrier screening of both parents is important when there is a family history or when the condition is prevalent in a population. If both parents are carriers of beta thalassaemia, each pregnancy carries a 25 percent chance of producing a child with beta thalassaemia major. Prenatal diagnosis through chorionic villus sampling (CVS) or amniocentesis is available for couples at high risk.
What Are the Treatment Options for Thalassaemia?
Regular Blood Transfusions
For patients with beta thalassaemia major, regular blood transfusions are the foundation of management. Transfusions maintain haemoglobin levels sufficient to support growth, development, and daily function, and suppress the bone marrow’s abnormal attempts to produce red blood cells, reducing complications such as bone changes and splenomegaly. They are typically administered every 2 to 4 weeks as a day-care procedure.
Amrita Hospitals provides packed red blood cell transfusions, day-care transfusion services, and blood bank support with screened blood products – essential for children and adults requiring lifelong transfusion therapy.
Iron Chelation Therapy
Every blood transfusion introduces iron into the body. The human body has no natural mechanism to excrete excess iron, so it accumulates in the liver, heart, endocrine glands, and other organs, causing progressive damage over time.
Iron chelation therapy uses medications to bind and remove excess iron:
- Deferoxamine – administered by subcutaneous infusion, typically overnight. Highly effective but requires careful monitoring for auditory and visual side effects at higher doses
- Deferasirox – an oral chelating agent, more convenient for long-term use
- Deferiprone – an oral agent with particular benefit for cardiac iron removal
Monitoring includes regular ferritin measurements, liver and cardiac MRI to quantify organ iron burden, and assessment of endocrine function.
Specialist Haematology Care
Beyond transfusions and chelation, comprehensive haematology management addresses:
- Enlarged spleen – splenectomy may be considered in selected patients with hypersplenism
- Growth and pubertal development in children
- Endocrine complications including hypothyroidism, diabetes, and hypogonadism related to iron overload
- Bone health management
- Infection risk, particularly following splenectomy
Genetic Counselling and Family Screening
Because thalassaemia is inherited, family screening is an integral part of management. Amrita Hospitals’ haematology team provides carrier testing, prenatal counselling, and family planning guidance. Identifying carrier status in family members – particularly siblings who may be potential bone marrow donors – is also clinically important when transplant is being considered.
Can Thalassaemia Be Cured With a Bone Marrow Transplant?
For eligible patients with beta thalassaemia major, bone marrow transplant represents the only currently available curative treatment. A successful transplant replaces the patient’s defective bone marrow with healthy donor stem cells, enabling the body to produce normal haemoglobin and eliminating the need for lifelong blood transfusions.
Who Is Eligible?
Outcomes from bone marrow transplant for thalassaemia are best when:
- The patient is a child or young adult – transplant outcomes are significantly better in younger patients, before iron overload has caused extensive organ damage
- A fully matched sibling donor is available
- The patient’s organ function is adequate – liver and cardiac health are assessed as part of the pre-transplant evaluation
- The patient is classified in a lower-risk transplant category based on the Pesaro risk classification system
Types of Transplant Available at Amrita Hospitals
Amrita Hospitals’ dedicated Blood and Marrow Transplant units perform:
- Matched sibling donor transplants
- Matched unrelated donor transplants
- Haploidentical (half-matched family donor) transplants – expanding access for patients without a fully matched sibling donor
For Sri Lankan families with a child newly diagnosed with beta thalassaemia major, early evaluation for bone marrow transplant – before iron overload becomes advanced – is the single most important step that maximises the chance of cure.
You can read more about the full bone marrow transplant process in our detailed article on bone marrow transplant in India for Sri Lankan patients, which covers eligibility, the transplant process, and recovery in detail.
How Does Amrita Hospitals Support Thalassaemia Patients?
Amrita Hospitals’ haematology and stem cell transplant programme at its centres in Kochi and Faridabad provides comprehensive support across every stage of the disease:
For Newly Diagnosed Patients
- Diagnosis confirmation and disease classification
- Initiation of transfusion programme
- Iron overload assessment and chelation therapy planning
- Genetic counselling and family screening
For Patients Already on Treatment
- Second opinions on transfusion and chelation management
- Advanced iron overload assessment using cardiac and liver MRI
- Review of chelation therapy effectiveness and adjustment
- Management of thalassaemia complications including endocrine, cardiac, and neurological issues
For Patients Considering Transplant
- Bone marrow transplant evaluation including Pesaro risk classification
- HLA typing of the patient and potential family donors
- Full pre-transplant workup
- Execution of matched sibling, unrelated donor, or haploidentical transplant
Paediatric Thalassaemia Care
Amrita Hospitals has dedicated paediatric haematology clinics for children with inherited blood disorders, providing age-appropriate management of thalassaemia from infancy through adolescence.
To understand the full range of haematology and transplant services available, explore blood disorder and transplant treatment options in India.
Why Do Sri Lankan Families Choose India for Thalassaemia Care?
- Dedicated haematology and bone marrow transplant units at Amrita Hospitals with specific experience in managing haemoglobinopathies including thalassaemia
- Amrita Hospitals pioneered micro blood stem cell transplantation in India – reflecting genuine institutional depth in stem cell transplantation
- Full spectrum of transplant options including matched sibling, unrelated donor, and haploidentical transplant
- Comprehensive iron overload management including cardiac and liver MRI quantification and access to all three major chelating agents
- Genetic counselling and family screening services integrated into the haematology programme
- Geographic proximity to Sri Lanka – short flight times reduce the burden of travel for patients managing a chronic condition requiring regular visits
- Accessible treatment compared to equivalent specialist care in Western countries or Singapore
How Do Sri Lankan Patients Access Thalassaemia Treatment in India?
- Gather your existing medical records – haemoglobin electrophoresis or HPLC results, full blood count, ferritin levels, transfusion history, and any specialist haematology letters
- Share these with Amrita Info Centre Sri Lanka for forwarding to the haematology team at Amrita Hospitals
- Receive an initial clinical assessment and recommended next steps
- Confirm your appointment and travel arrangements
- Apply for your medical visa with support from our team
For guidance on the visa process, our article on the Complete Guide to Medical Visa for India from Sri Lanka covers every documentation and application step.
For families whose child has recently been diagnosed and who want to understand all available options including transplant, exploring patient support and travel assistance services early is the most important step – transplant outcomes are significantly better when evaluation begins before advanced iron overload develops.
Frequently Asked Questions
Is thalassaemia curable? Beta thalassaemia major can be cured with a successful bone marrow transplant in eligible patients. Outcomes are best in younger patients with a matched sibling donor and without advanced organ damage from iron overload. For patients who are not transplant candidates, the condition is managed with regular transfusions and iron chelation therapy.
Can thalassaemia trait (minor) cause serious health problems? Thalassaemia trait typically causes mild anaemia or no symptoms and does not require treatment. However, knowing your carrier status is important for family planning. If both partners are carriers of beta thalassaemia, each pregnancy has a 25 percent chance of producing a child with thalassaemia major.
At what age is bone marrow transplant most successful for thalassaemia? Transplant outcomes are best in children under 7 years of age, before significant iron overload has accumulated and before organ damage has developed. Early evaluation is strongly recommended for newly diagnosed children with a potential matched sibling donor.
How often do thalassaemia major patients need blood transfusions? Most patients with beta thalassaemia major require transfusions every 2 to 4 weeks. The frequency depends on the individual patient’s haemoglobin levels, growth, and clinical response.
Can iron overload be reversed? Effective iron chelation therapy can reduce the body’s iron burden over time and in some cases partially reverse organ damage caused by early iron accumulation. The earlier chelation is started and the more consistently it is maintained, the better the long-term outcomes for organ health.
Can Sri Lankan patients get genetic counselling through Amrita Hospitals? Yes. Amrita Hospitals provides genetic counselling, carrier testing, and prenatal counselling for families affected by thalassaemia, including sibling donor screening and guidance for couples planning future pregnancies.
Conclusion
Thalassaemia treatment in India offers Sri Lankan patients and families access to a complete spectrum of haematological care – from structured transfusion programmes and advanced iron overload management, to bone marrow transplant evaluation and, for eligible patients, a genuine pathway to cure.
For Sri Lankan families managing a thalassaemia diagnosis, the most important step is early specialist evaluation. Whether the goal is optimising ongoing management, exploring transplant eligibility, or seeking a second opinion on current treatment, Amrita Info Centre Sri Lanka is here to support that process from Colombo, with clarity and without obligation.